Status:
TERMINATED
CPAP in Preeclampsia
Lead Sponsor:
University of Sydney
Collaborating Sponsors:
Royal Prince Alfred Hospital, Sydney, Australia
Conditions:
Preeclampsia
Hypertension
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Study design: Single blinded randomised control trial Planned sample size: 30 (women randomized 2:1 to receive either CPAP or no CPAP) Objectives: Primary objective: Assess the effects of nasal C...
Detailed Description
DESIGN Single blinded randomized control trial STUDY GROUPS Women diagnosed with preeclampsia by their treating physicians (BP\>140/90 and proteinuria\> 300mg in 24 hours) who are being managed either...
Eligibility Criteria
Inclusion
- Women 24-37 weeks pregnant
- Singleton pregnancy
- Primiparous and primigravid
- Maternal age 18-45 years
- Diagnosis of preeclampsia by their treating specialist (SBP\>140/90 and proteinuria\>300mg in 24 hours)
Exclusion
- A previous diagnosis of hypertension, cardiac, respiratory or renal disease.
- Any regular cardiac or respiratory medications (PRIOR to pregnancy and diagnosis of preeclampsia)
- Current smokers
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT02303834
Start Date
February 1 2015
End Date
January 1 2017
Last Update
May 3 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Hospital for Women
Sydney, New South Wales, Australia, 2031
2
Royal Prince Alfred Hospital
Sydney, New South Wales, Australia, 2050